{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:00:57Z","timestamp":1789945257108,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jbo.2019.100243","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T14:06:56Z","timestamp":1559916416000},"page":"100243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs"],"prefix":"10.1016","volume":"17","author":[{"given":"Spyros","family":"Kolovos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Nador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuvan","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Streetly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil K.","family":"Rabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D","family":"Chantry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwee","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Bowcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Drayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Prieto-Alhambra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Kassim","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Pinedo-Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jbo.2019.100243_bib0001","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016","volume":"4","author":"Cowan","year":"2018","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.jbo.2019.100243_bib0002","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.euf.2017.01.006","article-title":"Variability of sex disparities in cancer incidence over 30 years: the striking case of kidney cancer","volume":"4","author":"Scelo","year":"2017","journal-title":"Eur. Urol. Focus"},{"issue":"4","key":"10.1016\/j.jbo.2019.100243_bib0003","first-page":"350","article-title":"Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis","volume":"55","author":"Slovacek","year":"2008","journal-title":"Neoplasma"},{"issue":"2","key":"10.1016\/j.jbo.2019.100243_bib0004","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-0609.2004.00346.x","article-title":"Health related quality of life in patients with multiple myeloma undergoing a double transplantation","volume":"74","author":"Uyl-de Groot","year":"2005","journal-title":"Eur. J. Haematol."},{"issue":"4","key":"10.1016\/j.jbo.2019.100243_bib0005","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/10428194.2017.1361035","article-title":"Economic burden of multiple myeloma among patients in successive lines of therapy in the United States","volume":"59","author":"MacEwan","year":"2018","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.jbo.2019.100243_bib0006","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ejh.12876","article-title":"Economic burden of relapsed or refractory multiple myeloma: results from an international trial","volume":"99","author":"Robinson","year":"2017","journal-title":"Eur. J. Haematol."},{"issue":"9","key":"10.1016\/j.jbo.2019.100243_bib0007","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/leu.2016.380","article-title":"Trends in overall survival and costs of multiple myeloma, 2000\u20132014","volume":"31","author":"Fonseca","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jbo.2019.100243_bib0008","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1634\/theoncologist.2009-0203","article-title":"Current multiple myeloma treatment strategies with novel agents: a European perspective","volume":"15","author":"Ludwig","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.jbo.2019.100243_bib0009","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/asheducation-2005.1.353","article-title":"An update of the management of multiple myeloma: the changing landscape","volume":"1","author":"Reece","year":"2005","journal-title":"Hematol. Am. Soc. Hematol. Educ. Progr."},{"issue":"5","key":"10.1016\/j.jbo.2019.100243_bib0010","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jbo.2019.100243_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyx015","article-title":"Hospital episode statistics admitted patient care (HES APC)","volume":"46","author":"Herbert","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jbo.2019.100243_bib0012","unstructured":"Health and Social Care Information Centre, Hospital Episode Statistics. https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/hospital-episode-statistics."},{"key":"10.1016\/j.jbo.2019.100243_bib0013","unstructured":"NHS England, Supplementary technical definitions 2016\/17: aactivity, 2016."},{"issue":"11","key":"10.1016\/j.jbo.2019.100243_bib0014","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/bjc.2016.77","article-title":"Cost of care for cancer patients in England: evidence from population-based patient-level data","volume":"114","author":"Laudicella","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"8_suppl","key":"10.1016\/j.jbo.2019.100243_bib0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1200\/JCO.2017.35.8_suppl.30","article-title":"Disease complexity and economic burden on patients with colon cancer in the SEER-Medicare population","volume":"35","author":"Rodriguez","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.jbo.2019.100243_bib0016","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ijc.31362","article-title":"Common dietary patterns and risk of cancers of the colon and rectum: analysis from the United Kingdom Women's Cohort Study (UKWCS)","volume":"143","author":"Diego","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.jbo.2019.100243_bib0017","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/ije\/dyx155","article-title":"The Mediterranean diet and risk of colorectal cancer in the UK Women's Cohort Study","volume":"46","author":"Jones","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jbo.2019.100243_bib0018","series-title":"National Clinical Coding Standards OPCS-4","year":"2017"},{"key":"10.1016\/j.jbo.2019.100243_bib0019","unstructured":"Health and Social Care Information Centre, HES Data Dictionary: Admitted Patient Care, 2018."},{"key":"10.1016\/j.jbo.2019.100243_bib0020","unstructured":"The National Casemix Classifications Service, Guide to Unbundling, 2009."},{"key":"10.1016\/j.jbo.2019.100243_sbref0017","series-title":"The King's Fund","article-title":"How hospital activity in the NHS in England has changed over time","author":"Maguire","year":"2016"},{"issue":"21","key":"10.1016\/j.jbo.2019.100243_bib0022","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.2048.2048","article-title":"Epidemiology and clinical characteristics of patients with multiple myeloma in the United Kingdom","volume":"124","author":"Raluy","year":"2014","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.jbo.2019.100243_bib0023","article-title":"Diagnostic pathways of myeloma patients presenting to hospital care and relationship to end organ damage: an analysis from the team (tackling early morbidity and mortality in myeloma) trial in 977 patients","volume":"130","author":"Bowcock","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jbo.2019.100243_bib0024","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.hoc.2007.08.006","article-title":"Complications of multiple myeloma","volume":"21","author":"Blad\u00e9","year":"2007","journal-title":"Hematol.\/Oncol. Clin. North Am."},{"issue":"Suppl 1","key":"10.1016\/j.jbo.2019.100243_bib0025","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.6004\/jnccn.2010.0115","article-title":"Complications of multiple myeloma therapy, part 1: risk reduction and management of peripheral neuropathy and asthenia","volume":"8","author":"Richardson","year":"2010","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.jbo.2019.100243_bib0026","unstructured":"NHS England and NHS Improvement, National tariff payment system 2017\/18 and 2018\/19, 2016."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137419300284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137419300284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:17:02Z","timestamp":1761941822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137419300284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":26,"alternative-id":["S2212137419300284"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2019.100243","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2019.100243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100243"}}